[ad_1] Just published in AJO: https://t.co/3CP1ggDwGG “Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema”. This longitudinal modeling figure shows how anatomic precedes visual improvement after treatment for uveitic macular edema. #eye #retina https://t.co/Iw5VUjcikj [ad_2] Source by Thomas Ciulla, MD, MBA Return to …
[ad_1] RT @eyewireplus: .@REGENXBIO announced additional positive interim data from the ongoing phase 2 ALTITUDE trial of RGX-314 for the treatmen… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Our recent paper was “Editor’s Choice”: This post hoc analysis compared #suprachoroidal triamcinolone acetonide (CLS-TA) to other treatments for macular edema due to #uveitis. https://t.co/iFbR8A7DG4
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @Ophthalmologymg: @BauschLomb’s Xipere therapy offers hope to patients with macular edema associated with non-infectious uveitis. By Kar… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @EvolveMedEd: Want to Know More About the Future of Suprachoroidal Injections? Come check out this #CME series featuring a new supplemen… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Just presented “The Suprachoroidal Space and Suprachoroidal Delivery for Clinicians” at #Angiogenesis2022, covering key features of #suprachoroidal delivery: targeting & compartmentalization, drivers of durability & posterior flow, therapies in development
#eye #retina https://t.co/WYLuN9eb4B
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @RetinaToday: The push for longer-acting therapeutics has garnered us several long-duration corticosteroid therapies to choose from. Thi… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ThomasCiullaMD: Looking forward to presenting “The Suprachoroidal Space and Suprachoroidal Delivery for Clinicians” at next week’s Angi… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @ThomasCiullaMD: Honored to be recognized as a global expert in #maculardegeneration , a leading cause of irreversible vision loss: http…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @RetinaGlobal1: Gene therapy, specifically designed to neutralize #VEGF activity, may be the next approach to the treatment of #diabetic… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.